These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22379153)

  • 1. Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Kasahara Y; Hojo M; Nei T; Nakayama H; Motoi N; Urano S; Eda R; Yokoba M; Tsuchihashi Y; Nasuhara Y; Ishii H; Ebina M; Yamaguchi E; Inoue Y; Nakata K; Tazawa R
    Eur Respir J; 2012 Mar; 39(3):777-80. PubMed ID: 22379153
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
    Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
    Tazawa R; Hamano E; Arai T; Ohta H; Ishimoto O; Uchida K; Watanabe M; Saito J; Takeshita M; Hirabayashi Y; Ishige I; Eishi Y; Hagiwara K; Ebina M; Inoue Y; Nakata K; Nukiwa T
    Am J Respir Crit Care Med; 2005 May; 171(10):1142-9. PubMed ID: 15735059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Alveolar Proteinosis Syndrome.
    Suzuki T; Trapnell BC
    Clin Chest Med; 2016 Sep; 37(3):431-40. PubMed ID: 27514590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
    Xu KF; Chen Y; Guo ZJ; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupational inhalational exposure and serum GM-CSF autoantibody in pulmonary alveolar proteinosis.
    Xiao YL; Xu KF; Li Y; Li Y; Li H; Shi B; Zhou KF; Zhou ZY; Cai HR
    Occup Environ Med; 2015 Jul; 72(7):504-12. PubMed ID: 25995295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary alveolar proteinosis.
    Wang T; Lazar CA; Fishbein MC; Lynch JP
    Semin Respir Crit Care Med; 2012 Oct; 33(5):498-508. PubMed ID: 23001804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in Alveolar Macrophage Size in Refractory Autoimmune Pulmonary Alveolar Proteinosis After Treatment With Pioglitazone.
    Vis DC; Kelly MM; De Heuvel E; MacEachern PR
    J Bronchology Interv Pulmonol; 2020 Jul; 27(3):219-222. PubMed ID: 32569076
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary alveolar proteinosis associated with anti-GM-CSF antibodies in a child: successful treatment with inhaled GM-CSF.
    Price A; Manson D; Cutz E; Dell S
    Pediatr Pulmonol; 2006 Apr; 41(4):367-70. PubMed ID: 16475176
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody.
    Arai T; Kasai T; Shimizu K; Kawahara K; Katayama K; Sugimoto C; Hirose M; Okamoto H; Tachibana K; Akira M; Inoue Y
    Intern Med; 2020 Oct; 59(20):2539-2546. PubMed ID: 32611952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.
    Uchida K; Nakata K; Trapnell BC; Terakawa T; Hamano E; Mikami A; Matsushita I; Seymour JF; Oh-Eda M; Ishige I; Eishi Y; Kitamura T; Yamada Y; Hanaoka K; Keicho N
    Blood; 2004 Feb; 103(3):1089-98. PubMed ID: 14512323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
    Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosis.
    Nei T; Urano S; Itoh Y; Kitamura N; Hashimoto A; Tanaka T; Motoi N; Kaneko C; Tazawa R; Nakagaki K; Arai T; Inoue Y; Nakata K
    Clin Immunol; 2013 Dec; 149(3):357-64. PubMed ID: 24211842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune Pulmonary Alveolar Proteinosis: Evidence of the Pathogenicity of GM-CSF Antibodies.
    Le Gal A; Chabrol A; Brun AL; Fraboulet S; Couderc LJ; Salvator H
    Am J Respir Crit Care Med; 2021 Dec; 204(12):e134-e135. PubMed ID: 34129433
    [No Abstract]   [Full Text] [Related]  

  • 15. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
    Kavuru MS; Malur A; Marshall I; Barna BP; Meziane M; Huizar I; Dalrymple H; Karnekar R; Thomassen MJ
    Eur Respir J; 2011 Dec; 38(6):1361-7. PubMed ID: 21478218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why does the autoantibody against granulocyte-macrophage colony-stimulating factor cause lesions only in the lung?
    Nakata K; Kanazawa H; Watanabe M
    Respirology; 2006 Jan; 11 Suppl():S65-9. PubMed ID: 16423275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test.
    Bonfield TL; John N; Barna BP; Kavuru MS; Thomassen MJ; Yen-Lieberman B
    Clin Diagn Lab Immunol; 2005 Jul; 12(7):821-4. PubMed ID: 16002629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
    Tazawa R; Ueda T; Abe M; Tatsumi K; Eda R; Kondoh S; Morimoto K; Tanaka T; Yamaguchi E; Takahashi A; Oda M; Ishii H; Izumi S; Sugiyama H; Nakagawa A; Tomii K; Suzuki M; Konno S; Ohkouchi S; Tode N; Handa T; Hirai T; Inoue Y; Arai T; Asakawa K; Sakagami T; Hashimoto A; Tanaka T; Takada T; Mikami A; Kitamura N; Nakata K
    N Engl J Med; 2019 Sep; 381(10):923-932. PubMed ID: 31483963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report.
    Sato S; Akasaka K; Ohta H; Tsukahara Y; Kida G; Tsumiyama E; Kusano K; Oba T; Nishizawa T; Kawabe R; Yamakawa H; Amano M; Matsushima H; Takada T
    BMC Pulm Med; 2020 Apr; 20(1):84. PubMed ID: 32252718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice.
    Ferretti A; Fortwendel JR; Gebb SA; Barrington RA
    J Immunol; 2016 Jul; 197(2):470-9. PubMed ID: 27279372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.